Characterization of CD3+CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune rheumatic disease that may affect every organ or system in the body. We have shown previously that the TCR ab‡ subpopulation of CD3‡CD4⁷CD8⁷, DN T cells is expanded in patients with SLE and that double negative T cells express increased levels of activation markers compared both with healthy people and with patients with rheumatoid arthritis, (RA) as autoimmune controls. The aim of this study was to characterize these cells in terms of their ability to produce IL4, a Th2 cytokine, both spontaneously and after mitogen stimulation. It was found that a higher percentageof TCR ab‡ double negative T cells from patients with SLE contained IL4 constitutively than did the same population of cells from healthy people or from those with RA. After mitogen stimulation, there was no signi” cant difference in the amount of IL4 produced by each of the three groups. Further study of patients producing high levels of IL4 (about one third of the patients) indicated that they had a lower percentageof ab‡T cells in the double negative compartment than did patients with fewer IL4 containing cells.

Keywords

double negative IL4 SLE T cells

Get full access to this article

View all access options for this article.

References

Isenberg D , Horsfall A . Systemic lupus erythematosus. In: MoodisonPJ , Isenberg DA , Glass D , Woo P (eds). Oxford Textbook of Rheumatology. Oxford University Press: Oxford , 1998, pp 1145–1180.

Murison JG , Quaratino S , Kahan M , Verhoef A , Londei M . De” nition of unique traits of human CD4-CD8-alpha beta T cells . Clin Exp Immunol 1993; 93: 464–470 .

Anand A , Dean G , Querishi K , Isenberg D , Lydyard P . Characterisation of CD3‡, CD47, CD87 (double negative) T cells in patients with systemic lupus erythematosus (SLE) . Lupus 2002; 11: 493–500 .

Sumida T , Sakamoto A , Murata H et al. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis . J Exp Med 1995; 182: 1163–1168 .

Wilson SB , Kent SC , Patton KT et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes . [Published erratum appears in Nature 1999; 399(6731): 84.] Nature 1998; 391: 177–181 .

Oishi Y , Sumida T , Sakamoto A et al. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus . J Rheumatol 2001; 28: 275–283 .

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classi” cation of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271–1277 .

Hay EM , Bacon PA , Gordon C et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus . Q J Med 1993; 86: 447–458 .

Gladman DD , Goldsmith CH , Urowitz MB et al. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation . J Rheumatol 1994; 21: 1468–1471 .

10.

Arnett FC , Edworthy SM , Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classi” cation of rheumatoid arthritis . Arthritis Rheum 1988; 31: 315–324 .

11.

Dinter A , Berger EG . Golgi-disturbing agents . Histochem Cell Biol 1998; 109: 571–571 .

12.

Funauchi M , Ikoma S , Enomoto H , Horiuchi A . Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus . Scand J Rheumatol 1998; 27: 219–224 .

13.

Ferdinandez BR , Sanders VM , Mosmann TR , Vietta ES . Lymphokinemediated regulation of the proliferative response of clones of T helper and T helper 2 cells . J Exp Med 1988; 168: 543–558 .

14.

Funauchi M , Yu H , Sugiyama M et al. Increased interleukin-4 production by NK T cells in systemic lupus erythematosus . Clin Immunol 1999; 92: 197–202 .

15.

Kojo S , Adachi Y , Keino H et al. Dysfunction of T cell receptor AV24AJ18‡, BV11‡ double-negative regulatory natural killer T cells in autoimmune diseases . Arthritis Rheum 2001; 44: 1127–1138 .

16.

Klein W , Tromm A , Griga T et al. Interleukin-4 and interleukin-4 receptor gene polymorphisms in in‘ ammatory bowel diseases . Genes Immunol 2001; 2: 287–289 .

17.

Kanemitsu S , Takabayashi A , Sasaki Y et al. Association of inter-leukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus . Arthritis Rheum 1999; 42: 1298–1299 .

18.

Hernandez-Fuentes MP , Reyes E , Prieto A et al. Defective proliferative response of T lymphocytes from patients with inactive systemic lupus erythematosus . J Rheumatol 1999; 26: 1518–1526 .